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Abstract
Citrate-coated gold nanoparticles (AuNPs) are increasingly implemented in many
biomedical applications due to their novel electrochemical properties and further stabilization
against influence from the cellular environment by conjugation of citrate ligands to the exterior
of the gold nanocrystalline lattice. AuNPs have the ability to permeate the cell membrane
without disturbing the nucleus, with some size regimes, without producing any known toxic
effects. This work presents a collection and analysis of time-resolved fluorescence spectroscopy
data describing the interior of the bilayer of unsaturated 16:0 – 18:1 phosphatidylcholine large
unilamellar vesicles when exposed to 5, 10, and 20 [nm]-diameter citrate-capped AuNPs at
physiological temperature. A description of how the membrane was affected at the molecular
level was formulated by analyzing frequency-domain lifetime and time-resolved fluorescence
anisotropy decay measurements of AuNP-phosphatidylcholine assemblies.

KEYWORDS: Gold nanoparticles, large unilamellar vesicles, POPC, phosphatidylcholine,
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1 Background
Mammalian biomembranes typically consist of hundreds of lipid species and proteins
(25% to 65% protein by weight) and are abundant in phospholipids and cholesterol.1 A range of
different phospholipid classes exist within humans, of which phosphatidylcholine (PC) is one of
the most prevalent, and as such, is one of the more documented.2 Additionally, PC biomolecules
contribute to membrane-mediated operations within the cell, including enzyme activation and
cell signaling.
Conditions in the interior of the membrane bilayer dictate the efficacy of membrane
functions. Most mammalian cell barriers are composed of a semi-permeable amphiphilic
phospholipid bilayer plasma membrane with hydrophilic head groups oriented on the exterior of
the bilayer, and hydrophobic acyl groups oriented in the interior of the bilayer.3 Previous studies
have demonstrated ready diffusion of AuNPs through this membrane reportedly due to their size
and surface chemistries.4, 5 Furthermore, gold nanoparticles have increased stability after forming
surface bonds with citrate.6 A widely used method for synthesis of citrate-stabilized AuNPs is
the citrate method, which coats the gold nanocrystal and produces uniform nanoparticles tunable
in diameter in range of ~10–100 [nm] and determined by the ratio of sodium citrate to gold
starting material.7 Development of a more in-depth understanding of the potential nanotoxicity of
these and other attractive therapeutic nanomaterials appears to depend on exploration of
interactions of the many potential phospholipid-AuNP assemblies formed as a result of AuNP
exposure.
Currently, citrate-stabilized AuNPs are used for multiple biomedical applications,
including use as targeted drug carriers, thermal conductors for tumor ablation, and image
enhancing agents.8 AuNP surface modification is considered easy due to functionalization

permitting a wide range of biomolecules as ligands without compromising the integrity of the
nanoparticle.9 Interactions of light with the nanostructure of AuNPs are used to harness photon
energy to eradicate cancer cells using surface plasmon resonance.10 This oscillation is also
responsible for the optical properties that attribute to the efficiency and intensity that gold
nanoparticles can absorb and emit scattered light in biomedical imaging.11
Citrate-coated AuNPs have been observed in hyperspectral dark-field microscopy to
integrate in between bilayers of dimyristoyl PC large unilamellar vesicles (LUVs) when AuNP
diameter = 10 [nm], disrupting integrity of the phospholipid vesicle.12 It is beneficial to study a
range of interactions of AuNP-phospholipid assemblies at the molecular level to further
comprehension of physicochemical interactions and potential toxicological effects in future
cancer nanotechnology applications. A study of interactions in the interior of the lipid membrane
in this research was achieved by analysis frequency-domain lifetime and time-resolved
fluorescence anisotropy decay measurements of AuNP-LUV assemblies.
The fundamental concept of fluorescence involves three steps. First, a susceptible
molecule is excited by an incoming photon source, followed by vibrational relaxation of the
excited state electrons to the lowest energy level. Finally, this phenomenon results in the
emission of a photon of longer wavelength. Both frequency-domain lifetime and time-resolved
fluorescence anisotropy decay measurements inform of how accessible the population of
fluorescent probe molecule 1,6-diphenyl-1,3,5-hexatriene (DPH) embedded in a series of
unsaturated phosphatidylcholine molecules will be to water by probing the membrane interior
with light and electronically exciting DPH molecules embedded in the acyl chain region of the
lipid bilayer.

Fluorescence anisotropy is an analysis of the changing orientation of a susceptible
molecule in a medium with respect to time between the events of emission and absorption of
electromagnetic radiation.13 When the absorption event occurs, DPH retains polarization in the
emission, and polarizers placed in the path of incident and emission rays of light can be analyzed
by a fluorometer. In this research, absorption and emission events indicated alignment of the
dipole of the DPH molecules relative to the wave of absorbed and emitted light.
2 Purpose
The objective of this research is to further the understanding of biomembrane-AuNP
interactions and potential mechanisms of nanotoxicity in relation to biomedical applications of
citrate-stabilized AuNPs through collection and interpretation of time-resolved fluorescence
lifetime and anisotropy data resulting from experiments involving POPC exposure to citratecoated AuNPs. AuNPs of interest will range in diameter of 5, 10, and 20 [nm].
3 Materials and Methods
3.1 Molecules of Interest

Figure 1. POPC, DPH molecular structures and AuNP molecular representation (Note: ratio of citrate
molecules to gold molecules varies per diameter of nanosphere.14

3.2 Sample Preparation
Freeze-thaw cycles (8x) were applied to sample of 2.0 [mL, 8.1 mM] 16:0 – 18:1 1palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC) stock solution purchased from Avanti
Polar Lipids. POPC sample was stirred via vortexer for 10 seconds then 0.8 [mL] was extruded
11x through 0.2 [um] membrane filter paper to produce unilamellar lipid vesicles.
Three quartz cuvette samples were prepared for experimentation. Initially, each cuvette
contained identical solutions composed of 1.2 [mL, pH 7.2] 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) buffer with 0.022 [mL] extruded POPC LUVs to
produce 0.15 [mM] POPC concentration. Following 10 seconds of manual agitation of POPC in
HEPES buffer solution, 1.31 [uL] 1,6-diphenyl-1,3,5-hexatriene (DPH) dissolved in
tetrahydrofuran (THF) (stored at -20 °C) was additionally syringed into cuvette with solution to
yield a phospholipid/DPH ratio of 300:1. All samples were brought to physiological temperature
37.0 [°C] via water bath.
After data was collected for control samples, each cuvette was designated for 5 , 10 and
20 [nm] citrate-coated gold nanocrystals in water

(concentration 0.04 – 0.05 [mg/mL]),

purchased from NN-Labs. A low dosage range of 300.0 [uL] of each size AuNP was additionally
pipetted into its designated cuvette for data collection at 37.0 [°C]. For high dose range data set,
each sample cuvette contained 37.0 [°C] solution composed of 900.0 [uL] AuNPs in water with
0.022 [mL] extruded POPC LUVs, 1.2 [mL] HEPES buffer, and 1.31 [uL] DPH.
3.3 Measurements and Analysis
Time-resolved lifetime and anisotropy measurements of all samples were collected via
Chronos digital frequency domain spectrofluorometer. Anisotropy decay intensity data was

analyzed using a higher order mathematical model, known as the Brownian Rotational Diffusion
model, in order to attain information regarding molecular disorganization.1
4 Results
In the following tables, outline average fluorescence lifetime () measurements are
provided along with average rotational correlation time to rotate one radian ()  The rate of
rotation of the dipole around the z-axis propagating along the x-axis is defined as 𝑫⊥ .
Furthermore, the disorder parameter based on 𝑓(𝜃) is identified in the tables below as frandom.
The first set of data outline is in the 300.0 [L] AuNP low dose range followed by data collected
in the 900.0 [L] AuNP high dose range.
Table 1. Low Dose Range:
POPC [0.15 mM] LUVs with 300.0 [L] 0.04 – 0.05 [mg/mL] citrate-stabilized AuNPs

 [ns]

±

 [ns]

±

𝑫⊥ [ns]-1

±

𝒇𝒓𝒂𝒏𝒅𝒐𝒎

±

POPC

8.5

0.07

2.48

0.11

0.145

0.01

0.615

0.008

5nm

8.52

0.1

2.93

0.07

0.114

0.007

0.62

0.015

10nm

8.57

0.07

2.74

0.06

0.17

0.015

0.536

0.016

20nm

8.52

0.1

2.46

0.06

0.153

0.01

0.599

0.007

Table 2. High Dose Range:
POPC [0.15 mM] LUVs with 900.0 [L] 0.04 – 0.05 [mg/mL] citrate-stabilized AuNPs

 [ns]

±

 [ns]

±

𝑫⊥ [ns]-1

±

𝒇𝒓𝒂𝒏𝒅𝒐𝒎

±

POPC

8.5

0.07

2.48

0.11

0.145

0.01

0.615

0.008

5nm

7.16

0.2

0.244

0.06

1.21

0.2

0.561

0.01

10nm

7.95

0.15

1.57

0.18

0.669

0.15

0.388

0.04

20nm

8.29

0.1

2.295

0.06

0.174

0.02

0.572

0.022

Figures 2 and 3 display orientational probability distribution parameter 𝑓(𝜃)(sin 𝜃) with
respect to degrees from the membrane normal. The orientational distribution function requires
the general constraints
𝑓(𝜃) ≥ 0

(1)

∫0 𝑓(𝜃)(𝑠𝑖𝑛𝜃)𝑑𝜃 = 1

(2)

𝜋
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Figure 2. Orientational probability distribution of DPH probe in POPC bilayer with 300.0 [uL] 0.04 –
0.05 [mg/mL] citrate-stabilized AuNPs

Figures 2 and 3 display orientational probability distributions demonstrating the
phospholipid acyl chains cause the fluorescent probe molecule DPH to be nonrandom.
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Figure 3. Orientational probability distribution of DPH probe in POPC bilayer with 900.0 [uL] 0.04 –
0.05 [mg/mL] citrate-stabilized AuNPs

If there existed a scenario where DPH would be examined in a completely random
orientation, a disorder parameter exists where the probability distribution curve created under
random conditions can be overlapped with the empirically derived orientational probability
distributions as seen in Figure 4.
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Figure 4. The probability of a random orientation overlapped with the orientational probability
distribution displays the deviation displayed by the 10 [nm] AuNP samples.

Frequency-domain lifetime measurements showed no significant change in fluorescence
lifetime of DPH molecules in the administration of the low dose range of AuNPs (300.0 [uL] 0.04
– 0.05 [mg/mL]).
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Figure 5. Rotational correlation lifetime of DPH probe in POPC bilayer for samples in high dose range

Fluorescence lifetime measurements were noteworthy in the high dose range of AuNPPOPC LUV assemblies (AuNP 900.0 [uL] 0.04 – 0.05 [mg/mL]).
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Figure 6. High-dose range fluorescent probe DPH lifetime before being exposed to water

5 Discussion
The behavior of the DPH molecule was used to learn about acyl chain packing and
subsequent structural properties in the POPC bilayers induced by exposure to citrate-capped
AuNPs. In both low and high dosage ranges, including all size AuNPs, loss of density in packing
of phospholipid head groups occurred due to increased water penetration into membrane. All
sizes of AuNPs in both dosage ranges increased the rate of molecular rotational motion in the
membrane bilayer. In the low dose range (300.0 [uL] citrate-stabilized AuNP in water) no
significant change in fluorescence lifetime was identified. Slight variances were detected
between 5 [nm] diameter AuNPs and 10 [nm] size AuNPs, but the effects on POPC LUVs were
near identical between 5 [nm] and 20 [nm] diameter AuNPs in the low dose range. Suppression
of orientations between two main populations was detected with 10 [nm] diameter AuNPs in low
dose range.
Variances according to AuNP diameter were detected in samples of high dose range
(900.0 [uL] citrate-capped AuNP in water). Evidence of rupture of POPC vesicles was observed
when AuNP diameter equaled 5 [nm]. A more severe suppression of orientations between two
main populations occurred when AuNP diameter equaled 10 [nm]. AuNPs with diameter of 20
[nm] exhibited a very small effect of restricting mobility of POPC LUVs.
The most notable demonstration of nanotoxicity with AuNP-POPC assemblies was in the
high dose range when AuNP diameter was equal to 5 [nm]. The cause of vesicle lysis could
potentially be due to chemical functionalization of POPC-AuNP assemblies or could be caused
by decreasing the size of the nanoparticle to favor vesicle internalization.15

In summary, when 16:0 – 18:1 POPC unilamellar vesicles 200 [nm] diameter were dosed
with 300.0 [uL] 0.04 – 0.05 [mg/mL] citrate-coated AuNPs of 5, 10 and 20 [nm] diameter, an
increase in POPC membrane rigidity was observed, but effects of all sizes of AuNPs in this
dosage range expressed nominal effects on POPC membrane bilayer composition. POPC LUVs
dosed with 900.0 [uL] 0.04 – 0.05 [mg/mL] citrate-stabilized AuNPs showed more significant
effects on lipid bilayers, including rupture of vesicles when AuNP diameter was equal to 5 [nm].
When AuNP diameter equaled 10 [nm], suppression of orientations between two main
populations occurred. AuNP-LUV assemblies incorporating 20 [nm] diameter AuNPs had a
nominal effect on POPC when administered to LUVs in the high dose range.
An emergence of a range of biomedical applications of engineered nanomaterials and the
potential risk of toxic effects makes it crucial to investigate and understand the physical
chemistry of the interactions of biomembranes and nanoparticles16,17. Future research to
determine the concentration threshold of citrate-capped AuNPs correlating with vesicle
decomposition when exposed to 5 [nm] AuNPs will be beneficial documentation for biological
applications where citrate-stabilized AuNPs are used to mediate cellular interventions.

Abbreviations
AuNP: gold nanoparticle
LUV: large unilamellar vesicle
PC: phosphatidylcholine
DPH: 1,6-diphenyl-1,3,5-hexatriene
POPC: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
THF: tetrahydrofuran
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
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